Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130259870A1
SERIAL NO

13573436

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Aspects of the invention provides provide methods for treatment of NASH and associated liver fibrosis. In particular, aspects of the invention relate to the therapeutic formulation comprising a galactomannan polysaccharide compound for the treatment of NASH and associated liver fibrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALECTIN THERAPEUTICS INC4960 PEACHTREE INDUSTRIAL BLVD SUITE 240 NORCROSS GA 30071

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Klyosov, Anatole A Newton, US 17 251
Traber, Peter G Duluth, US 24 127
Zomer, Eliezer Newton, US 54 832

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation